COLL vs MKC · P/E 17, rev $181.9M vs P/E 8.4, $13.56B cap
Collegium Pharmaceutical Inc (COLL) versus McCormick & Company Incorporated (MKC) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
McCormick & Company Incorporated (MKC) is a packaged foods company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
MKC does not have a complete income-statement cache yet.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. MKC currently screens at market cap $13.56B and trailing P/E 8.4.
Not investment advice. Open the COLL and MKC stock pages for the full models.
Not investment advice.